Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723941 | SCV000226724 | uncertain significance | not provided | 2014-05-26 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000208484 | SCV000264028 | uncertain significance | Primary dilated cardiomyopathy | 2015-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000247360 | SCV000320550 | likely benign | Cardiovascular phenotype | 2023-06-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000321873 | SCV000372346 | benign | Left ventricular noncompaction 10 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV001094061 | SCV000372348 | uncertain significance | Hypertrophic cardiomyopathy 4 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Invitae | RCV000267890 | SCV000546490 | likely benign | Hypertrophic cardiomyopathy | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000723941 | SCV000616974 | uncertain significance | not provided | 2023-06-10 | criteria provided, single submitter | clinical testing | Has been reported as a variant of uncertain significance in an individual with cardiomyopathy (Pottinger et al., 2020).; Functional studies have demonstrated that p.(R574Q) does not result in a significant splicing defect (Ito et al., 2017); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 33782553, 34935411, 32009526, 28679633) |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000624304 | SCV000740354 | uncertain significance | Primary familial hypertrophic cardiomyopathy | 2016-05-18 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170954 | SCV001333609 | uncertain significance | Cardiomyopathy | 2021-03-05 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001170954 | SCV001347632 | likely benign | Cardiomyopathy | 2020-02-13 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000035429 | SCV000059077 | uncertain significance | not specified | 2009-02-26 | no assertion criteria provided | clinical testing |